• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos

The buy-in from other companies into the space has been far larger.
By KEVIN CURRAN
Dec 20, 2018 | 11:31 AM EST
Stocks quotes in this article: TLRY, BUD, MO, CRON

Is Tilray's (TLRY) weed wheeling and dealing news Thursday taking shares too high?

The Canadian cannabis stock was soaring on Thursday amid the news of its partnership with Anheuser Busch InBev (BUD) . The deal, which inks one of the highest profile cannabis names to perhaps the highest profile name in alcoholic beverages, is proving a big boost, buoying the stock to about a 10% gain in morning trading.

"What this tells you is how big the market is," Jim Cramer pointed out from the floor of the NYSE this morning. 

Yet, the buy-in from other companies into the space has been far larger.

That could be obscuring the actual details of the deal that pale in comparison to that of some of its peers and might make the day's bounce outsized.

Cronos Comparison

Top of mind for many cannabis investors is the recent blockbuster agreement between Tilray competitor Cronos (CRON) with cigarette conglomerate Altria (MO) .

The first major difference is between Tilray and Cronos is that Altria, the maker of Marlboro cigarettes, actually purchased an equity stake.

The 45% stake in Cronos valued at $1.8 billion, which includes $1.05 billion option to purchase an additional 10% in the future, nearly doubles the valuation of Cronos and gives the company a big base to attack the Canadian market as it matures and possibly the increasingly more open American market.

"The partnership does not appear to provide a route to control of Tilray," Jefferies analyst Edward Mundy clarified. "It offers a lower risk approach given reputational considerations for ABI as a global brewer."

At the very least, it represents far less of a buy in from BUD than Altria was willing to inhale.

Additionally, Tilray's partnership by comparison is more of an exploratory effort that offers nothing in terms of valuation speculation, despite its over $500 million boost to Tilray's market cap.

Given that the infusion to the Tilray joint venture only stands at $50 million, such a boost appears a bit overdone. Given Cronos jumped by about twice as much on a direct infusion of 36 times more capital the volatility of Tilray comes further into focus. 

Additionally, the company remains well below its historic highs. In fact, it remains at nearly one quarter of its peak levels.

So, while the buy-in from a historic brewery is a major benefit to the industry, maybe the market is overplaying the impact on Tilray specifically.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Rumor Mill | Takeover Possibility | Investing | Stocks | Marijuana | United States | Canada | Analyst Actions | Cannabis

More from Stocks

The Week Ahead: Housing, Fed Minutes and 13 Tell-Tale Earnings Reports to Watch

Chris Versace
Feb 18, 2019 2:00 PM EST

A shortened week still brings key economic numbers and earnings results.

Who Will Be the Winners in the Increasingly Crowded Streaming Services Battle?

Chris Versace
Feb 18, 2019 10:31 AM EST

How many streaming services do we really need?

This Bank Stock Yields 4% and Just Became a Dividend Aristocrat

Nick McCullum
Feb 16, 2019 2:00 PM EST

This Connecticut-based bank is a rare financial sector stock that has increased its dividend for 25 consecutive years.

Kass: Stop the Nonsense That There Is No Inflation; 8 Bad Things for Stocks

Doug Kass
Feb 16, 2019 12:00 PM EST

The Fed shouldn't breathe easy just yet.

Don't Just Sit There, Work the Trade

James "Rev Shark" DePorre
Feb 16, 2019 10:00 AM EST

The important thing to keep in mind when working a trade is that we are embracing the fact that we can't predict the future.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:01 PM EST KEVIN CURRAN

    Pepsi Kicks off 2019 on a Positive Note

    Pepsi's earnings may not have been immaculate, but...
  • 10:08 AM EST BOB LANG

    Rolling up the Arista

    on Tuesday this week I posted a trade idea here an...
  • 08:11 AM EST KEVIN CURRAN

    Pepsi Earnings Call Notes

    As my first article is in edit, here are some sele...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login